The regulation of Curcumin on the amyloidogentic pathaway of APP in Alzheimer's disease

Chinese Pharmacological Bulletin

Volumn 25, Issue 3, 2009, Pages

  Zhang, Hong Mei ^a   Zhang, Xiong ^a   Li, Yu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; APP; A ; BACE1; Curcumin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CURCUMIN; LIPOFECTAMIN 2000; LIPOFECTAMINE; MESSENGER RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 68549101647     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yang J H, Huang H S, Zha X D, Chen Q F. Research progress of pathogenesis, early diagnosis and therapy in Alzheimers disease[J]. Chin Pharmacol Bull, 2007,23(7):847-850
2. Shishir S H, Gautam S E, Bharatb A G, et al. Curcumin: getting back to the roots[J]. Ann N Y Acad Sci, 2005,1056:206-217
3. Ono K, Naiki H, Yamada M, et al. The devolepment of preventives and therapeutics for Alzheimer's disease that inhibite the formation of beta-amyloid fibrils (fAbeta), as well as destabize preformed fAbta[J]. Curr Pham Des, 2006,12(33):4357-4375
4. Zhang Y W, Xu H. Molecular and cellular mechanisms for alzheimer's disease: understanding APP metabolism[J]. Curr Mol Med, 2007,7(7):687-696 (Pubitemid 350201668)
5. Cai H, Wang Y, McCarthy D, et al. BACE1 is the major beta - secretase for generation of A beta peptides by neurons[J]. Nat Neurosci, 2001,4(3):233-234 (Pubitemid 32194867)
6. Hook V Y, Reisine T D. Cysteine proteases are the major β-secretase in the regulated secretory pathway that provides most of the β-amyloid in Alzheimer's disease: role of BACE1 in the constitutive secretory pathway[J]. Neurosci Res, 2003,74(3):393-405.
7. Haray J A, Higgins G A. Alzheimer's disease: the amyloid cascade hypothesis[J]. Science, 1992,256:184-185
8. Hardy J, Selkoe D J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002,297(5580):353- 356 (Pubitemid 34790756)
9. Wang Y H, Du G H. A drug target for Alzheimer's disease: β-secretase[J]. Chin Pharmacol Bull, 2003,19(6):609-613 (Pubitemid 36919047)
10. Aggarwal B B, Sundaram C, Malani N, et al. Curcumin: the Indian solid gold[J]. Adv Exp Med Biol, 2007,595:1-75.
11. Yamada K, Nabeshima T. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs[J]. Pharmacol Therapeut, 2000,88(2):93-113. (Pubitemid 32057133)
12. Lim G P, Chu T, Yang F, et al. The curry spice Curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse[J]. J Neuros, 2001,21(21):8370-8377 (Pubitemid 33051435)
13. Yang F, Lim G P, Begum A N, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo[J]. J Biol Chem, 2005,280(7):5892-901. (Pubitemid 40280072)
14. Peretto I, La Porta E. Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective[J]. Curr Top Med Chem, 2008,8(1):38-46. (Pubitemid 351791045)